NMC Health Plc (LSE:NMC) agreed to acquire 70% stake in As Salama Hospital for $29.2 million on August 29, 2016. The total purchase consideration of $29.195 million includes consideration paid of $26.4 million and deferred consideration payable of $2.8 million in 2018. The transaction are expected to be significantly accretive to NMC's EPS in 2017 with an attractive ROIC in excess of NMC's cost of capital. Matthew Cole and Shane Dolan of FTI Consulting acted as public relations advisors for NMC Tarek El-Assra, Philip Dowsett, Robbie Nakarmi and Tareq Obeidat of Morgan Lewis acted as legal advisor for NMC. NMC Health Plc (LSE:NMC) completed the acquisition of a 70% stake in As Salama Hospital on January 2, 2017. The transaction received regulatory approvals.